Has reducing fine particulate matter and ozone caused reduced mortality rates in the United States?
Between 2000 and 2010, air pollutant levels in counties throughout the United States changed significantly, with fine particulate matter (PM2.5) declining over 30% in some counties and ozone (O3) exhibiting large variations from year to year. This history provides an opportunity to compare county-level changes in average annual ambient pollutant levels to corresponding changes in all-cause (AC) and cardiovascular disease (CVD) mortality rates over the course of a decade. Past studies have demonstrated associations and subsequently either interpreted associations causally or relied on subjective judgments to infer causation. This article applies more quantitative methods to assess causality. This article examines data from these "natural experiments" of changing pollutant levels for 483 counties in the 15 most populated US states using quantitative methods for causal hypothesis testing, such as conditional independence and Granger causality tests. We assessed whether changes in historical pollution levels helped to predict and explain changes in CVD and AC mortality rates. A causal relation between pollutant concentrations and AC or CVD mortality rates cannot be inferred from these historical data, although a statistical association between them is well supported. There were no significant positive associations between changes in PM2.5 or O3 levels and corresponding changes in disease mortality rates between 2000 and 2010, nor for shorter time intervals of 1 to 3 years. These findings suggest that predicted substantial human longevity benefits resulting from reducing PM2.5 and O3 may not occur or may be smaller than previously estimated. Our results highlight the potential for heterogeneity in air pollution health effects across regions, and the high potential value of accountability research comparing model-based predictions of health benefits from reducing air pollutants to historical records of what actually occurred..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Annals of epidemiology - 25(2015), 3, Seite 162 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cox, Jr, Louis Anthony Tony [VerfasserIn] |
---|
Links: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1958766399 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1958766399 | ||
003 | DE-627 | ||
005 | 20230714145629.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1958766399 | ||
035 | |a (DE-599)GBVOLC1958766399 | ||
035 | |a (PRQ)p834-2bd0556ad7dc76679c8eb893f83d73111ae9e2069eeb041cca7f05c958bb9f0e0 | ||
035 | |a (KEY)0200569720150000025000300162hasreducingfineparticulatematterandozonecausedredu | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
100 | 1 | |a Cox, Jr, Louis Anthony Tony |e verfasserin |4 aut | |
245 | 1 | 0 | |a Has reducing fine particulate matter and ozone caused reduced mortality rates in the United States? |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Between 2000 and 2010, air pollutant levels in counties throughout the United States changed significantly, with fine particulate matter (PM2.5) declining over 30% in some counties and ozone (O3) exhibiting large variations from year to year. This history provides an opportunity to compare county-level changes in average annual ambient pollutant levels to corresponding changes in all-cause (AC) and cardiovascular disease (CVD) mortality rates over the course of a decade. Past studies have demonstrated associations and subsequently either interpreted associations causally or relied on subjective judgments to infer causation. This article applies more quantitative methods to assess causality. This article examines data from these "natural experiments" of changing pollutant levels for 483 counties in the 15 most populated US states using quantitative methods for causal hypothesis testing, such as conditional independence and Granger causality tests. We assessed whether changes in historical pollution levels helped to predict and explain changes in CVD and AC mortality rates. A causal relation between pollutant concentrations and AC or CVD mortality rates cannot be inferred from these historical data, although a statistical association between them is well supported. There were no significant positive associations between changes in PM2.5 or O3 levels and corresponding changes in disease mortality rates between 2000 and 2010, nor for shorter time intervals of 1 to 3 years. These findings suggest that predicted substantial human longevity benefits resulting from reducing PM2.5 and O3 may not occur or may be smaller than previously estimated. Our results highlight the potential for heterogeneity in air pollution health effects across regions, and the high potential value of accountability research comparing model-based predictions of health benefits from reducing air pollutants to historical records of what actually occurred. | ||
540 | |a Nutzungsrecht: Copyright © 2015 Elsevier Inc. All rights reserved. | ||
650 | 4 | |a Air Pollution - adverse effects | |
650 | 4 | |a Air Pollutants - analysis | |
650 | 4 | |a Cardiovascular Diseases - mortality | |
650 | 4 | |a Air Pollution - analysis | |
650 | 4 | |a Ozone - adverse effects | |
650 | 4 | |a Cardiovascular Diseases - chemically induced | |
650 | 4 | |a Mortality - trends | |
650 | 4 | |a Particulate Matter - adverse effects | |
650 | 4 | |a Air Pollutants - adverse effects | |
700 | 1 | |a Popken, Douglas A |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Annals of epidemiology |d New York, NY : Elsevier, 1990 |g 25(2015), 3, Seite 162 |w (DE-627)170558673 |w (DE-600)1074355-8 |w (DE-576)026324385 |x 1047-2797 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2015 |g number:3 |g pages:162 |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25571792 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 25 |j 2015 |e 3 |h 162 |